Dynemicin A
Latest Information Update: 29 Mar 2008
At a glance
- Originator Bristol-Myers Squibb
- Class Anthraquinones; Cytostatic antibiotics; Enediynes
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Cancer
Most Recent Events
- 18 May 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 18 May 2001 No-Development-Reported for Cancer in Japan (Unknown route)